














































































Variables No. of events RRa ９５％ CI P‐value
Men
S‐β２M（＞＝２．３vs．＜２．３mg/l） ３９ ２．６８ １．０２‐７．０３ ０．０５
S‐Cr（＞＝１．４vs．＜１．４mg/dl） ３９ ２．１１ ０．６６‐６．６８ ０．２１
C‐β２M（＞＝１．０vs．＜１．０％C‐Cr） ３８ ２．２２ ０．８０‐６．１５ ０．１２
C‐Ua（＞＝２０vs．＜２０％C‐Cr） ３９ １．７４ ０．８０‐３．８０ ０．１７
U‐β２M（＞＝１，０００vs．＜１，０００µg/g cr.） ４１ ２．０５ ０．９４‐４．４７ ０．０７
U‐Cd（＞＝１０．０vs．＜１０．０µg/g cr.） ４１ １．８３ ０．８３‐４．０３ ０．１３
Women
S‐β２M（＞＝２．３vs．＜２．３mg/l） ４９ １．９７ ０．９９‐３．９０ ０．０５
S‐Cr（＞＝１．２vs．＜１．２mg/dl） ４９ ３．０４ １．５０‐６．１５ ０．００２
C‐β２M（＞＝１．０vs．＜１．０％C‐Cr） ４７ ２．４４ １．３０‐４．６０ ０．００６
C‐Ua（＞＝２０vs．＜２０％C‐Cr） ４７ １．２１ ０．６５‐２．２６ ０．５５
U‐β２M（＞＝１，０００vs．＜１，０００µg/g cr.） ４７ ２．０５ １．０５‐４．０１ ０．０４
U‐Cd（＞＝１０．０vs．＜１０．０µg/g cr.） ４７ ０．８２ ０．４３‐１．５９ ０．５６
aAdjusted for age at baseline, body mass index, blood pressure and serum total cholesterol levels.
RR, rate ratio, CI, confidence interval, S-β２M, serum β２-microglobulin, S-Cr, serum creatinine,
C-β２M, β２-microglobulin clearance, C-Cr, creatinine clearance, C-Ua, uric acid clearance,
U-β２M, urinary β２-microglobulin, U-Cd, urinary cadmium, cr., creatinine.
























































































梢血中 HTLV-I proviral DNA量（または HTLV-I感染細
胞数）と高い相関があることが判明している。したがって，





























伴う胃壁の炎症反応減弱による Helicobacter pylori の持
続感染阻害）と増加する場合（HTLV-IとHepatitis C virus
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Risk assessment of environmental factors and contribution to disease prevention
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SUMMARY
The research interest of authors has focused on the risk assessment of environmental pollutants
such as cadmium and dioxin-related compounds, and epidemiology of human T-cell lymphotropic
virus type-I（HTLV-I）infection. The authors（１）showed that low-molecular weight proteinuria
and reduced glomerular filtration rate caused by environmental cadmium were strongly associated
with shortened survival，（２）clarified serological risk factors for development of adult T-cell
leukemia/lymphoma among asymptomatic HTLV-I carriers（plasma levels of soluble interleukin２-
receptor＞＝５００U/ml and HTLV-I antibody titer＞＝１，０２４），（３）conducted the first prospective
study of HTLV-I infection and development of malignances other than ATL, and found a significantly
reduced risk of gastric cancer among HTLV-I carriers, and（４）by a cooperative study, clarified a
¨new pathogenicity of HTLV-I（association with Sjogren’s syndrome）.
Key words : cadmium, dioxins, human T-cell lymphotropic virus type-I, risk assessment, epidemiology
環境要因の健康リスク評価 ３７
